CompletedNCT05686239
This study exists to compare options and see whether the medication RL-007 offers something meaningfully different. Researchers are trying to understand whether the medication RL-007 can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- Bulgaria, Czech Republic, Poland, United States
- Sponsor
- Recognify Life Sciences
- Condition
- Schizophrenia
CompletedNCT05905601
This study exists to see whether psychoeducation, a guided learning and support program, is workable and worth testing more broadly. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 30 Years
- Countries
- United States
- Sponsor
- University of Washington
- Condition
- Schizophrenia
CompletedNCT04752449
This study exists to explore whether cognitive behavioural therapy, a structured talking treatment, could improve care and understanding. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Canada
- Sponsor
- University of Toronto
- Condition
- Schizophrenia
CompletedNCT03814967
This study exists to compare options and see whether brain scans or other body measurements offers something meaningfully different. Researchers are trying to understand whether brain scans or other body measurements can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- United States
- Sponsor
- University of California, Davis
- Condition
- Schizophrenia
CompletedNCT05703698
This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Canada
- Sponsor
- University of Toronto
- Condition
- Schizophrenia
CompletedNCT04756388
This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Canada
- Sponsor
- University of Toronto
- Condition
- Schizophrenia
CompletedNCT06226779
This study exists to understand how this type of care holds up over time after the earliest research stage. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 20 Years to 65 Years
- Countries
- Taiwan
- Sponsor
- Chang Gung Memorial Hospital
- Condition
- Schizophrenia
CompletedNCT05443724
This study exists to understand how the medication CVL-231 holds up over time after the earliest research stage. For people living with Schizophrenia, that matters because care needs to work in daily life, not just in theory.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Bulgaria, Hungary, United States, Ukraine
- Sponsor
- AbbVie
- Condition
- Schizophrenia
CompletedNCT06440200
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand what a digital app or remote support tool could change in day-to-day care and decision-making.
SchizophreniaOtherOver 18 Years
- Countries
- Taiwan
- Sponsor
- National Taiwan University Hospital
- Condition
- Schizophrenia
CompletedNCT03708315
This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Yale University
- Condition
- Schizophrenia
WithdrawnNCT05469815
This study exists to see whether a digital app or remote support tool is workable and worth testing more broadly. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.
SchizophreniaOtherFrom 15 Years to 20 Years
- Countries
- Global
- Sponsor
- Centre Hospitalier Departemental Vendee
- Condition
- Schizophrenia
CompletedNCT07076940
This study exists to understand how psychoeducation, a guided learning and support program, holds up over time after the earliest research stage. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can give earlier or clearer feedback during care.
SchizophreniaOtherOver 18 Years
- Countries
- Turkey
- Sponsor
- Halic University
- Condition
- Schizophrenia
CompletedNCT03677635
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United Kingdom
- Sponsor
- King's College London
- Condition
- Schizophrenia
CompletedNCT05438160
This study exists to see whether a digital app or remote support tool can play a useful role in care. Researchers are trying to understand whether a digital app or remote support tool can make support easier to access outside standard clinic visits.
SchizophreniaOtherFrom 18 Years to 64 Years
- Countries
- United States
- Sponsor
- Click Therapeutics, Inc.
- Condition
- Schizophrenia
CompletedNCT03034356
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- VA Office of Research and Development
- Condition
- Schizophrenia
WithdrawnNCT04761861
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand what this type of care could change in day-to-day care and decision-making.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- Egypt
- Sponsor
- Sadat City University
- Condition
- Schizophrenia
CompletedNCT05545111
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can better prevent setbacks and support longer-term stability.
SchizophreniaOtherFrom 18 Years to 55 Years
- Countries
- United States
- Sponsor
- Neurocrine Biosciences
- Condition
- Schizophrenia
CompletedNCT05282186
This study exists to see whether a digital app or remote support tool can make care clearer and more responsive. Researchers are trying to understand whether a digital app or remote support tool can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Beth Israel Deaconess Medical Center
- Condition
- Schizophrenia
CompletedNCT03930225
This study exists to compare options and see whether psychoeducation, a guided learning and support program, offers something meaningfully different. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can give earlier or clearer feedback during care.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- Egypt
- Sponsor
- Mansoura University
- Condition
- Schizophrenia
TerminatedNCT05182476
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- Bulgaria, Czech Republic, Serbia, Spain, United States
- Sponsor
- Neurocrine Biosciences
- Condition
- Schizophrenia
CompletedNCT00306475
This study exists to explore whether a medication treatment could improve care and understanding. Researchers are trying to understand whether a medication treatment can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- United States
- Sponsor
- Northwestern University
- Condition
- Schizophrenia
TerminatedNCT06949657
This study exists to explore whether acceptance and commitment therapy, a talking treatment, could improve care and understanding. Researchers are trying to understand whether acceptance and commitment therapy, a talking treatment, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherOver 60 Years
- Countries
- China
- Sponsor
- Third People's Hospital, Huzhou City, Zhejiang Province, China
- Condition
- Schizophrenia
CompletedNCT02237235
This study exists to compare options and see whether the medication MMFS-202 offers something meaningfully different. Researchers are trying to understand whether the medication MMFS-202 can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 60 Years
- Countries
- United States
- Sponsor
- Northwestern University
- Condition
- Schizophrenia
CompletedNCT04282915
This study exists to understand how a digital app or remote support tool holds up over time after the earliest research stage. Researchers are trying to understand whether a digital app or remote support tool can work better when mental health difficulties overlap with substance use.
DepressionOtherOver 16 Years
- Countries
- Nepal
- Sponsor
- George Washington University
- Condition
- Depression
CompletedNCT06284096
This study exists to understand what helps psychoeducation, a guided learning and support program, work in everyday practice, not just under ideal conditions. Researchers are trying to understand whether psychoeducation, a guided learning and support program, can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 65 Years
- Countries
- Turkey
- Sponsor
- Istanbul University - Cerrahpasa
- Condition
- Schizophrenia